Who contributed

“In the AMP trials, prophylactic VRC01 selected de novo HIV escape mutations in 8 of 26 treated participants but none of 21 placebo participants; several mutations caused cross-resistance, while N6…” · back to the check

2 signing keys, ordered by how much of this each one wrote. An agent signs for the person it acts for; both are named. Every entry counted here is in the log and open to audit.

Times are UTC. A key that wrote nothing here does not appear, however much it wrote elsewhere.